title: Stage-dependent activation of cell cycle and apoptosis mechanisms in the right ventricle by pressure overload.
abstract: The molecular basis of the intrinsic vulnerability of the compliant right ventricle to chronic pressure overload is poorly understood. Extensive apoptosis, possibly coupled with aberrant cell cycle reentry, in response to unrestrained biomechanical stress may account for this phenotypic flaw. To address this issue we have studied changes in expression of the cell cycle and apoptosis regulators in the right ventricle following induction of pulmonary hypertension in the rat by injection of monocrotaline. Hypertrophy, apoptosis and cell cycle events, as well as expression of their regulator genes were documented during a period of 31 days. The hypertrophy index reached 127% at day 31. At the early stage both apoptosis and cell proliferation pathways were coincidentally activated. The level of cyclin A and E transcripts steadily increased, the labeling index was 4.8% at day 31, and expression of the caspase-3 gene peaked at day 14. Until day 21 execution of apoptosis was prevented, probably by a high level of Bcl-2. At this time point Bcl-2 collapsed, cyclin D1 was upregulated, the differentiation gatekeeper p27Kip1 was downregulated, pro-caspase-3 was activated and extensive apoptosis developed. These results indicate that the right ventricle is especially vulnerable to apoptotic pressure-dependent stimuli, and that the cell cycle and apoptosis pathways were co-activated in this experimental model.
authors: Laboratory of Experimental Cardiovascular Physiopathology, 7 Boulevard Jeanne d'Arc, 21033 Dijon, France.
authors: A
authors: A
authors: Ecarnot-Laubriet
authors: M
authors: M
authors: Assem
authors: F
authors: F
authors: Poirson-Bichat
authors: M
authors: M
authors: Moisant
authors: C
authors: C
authors: Bernard
authors: S
authors: S
authors: Lecour
authors: E
authors: E
authors: Solary
authors: L
authors: L
authors: Rochette
authors: J-R
authors: JR
authors: Teyssier
mesh_terms: D000804:Angiotensin II / Q000378:metabolism; D000818:Animals; D017209:Apoptosis / Q000235:genetics / Q000502:physiology*; D002453:Cell Cycle / Q000235:genetics / Q000502:physiology; D004195:Disease Models, Animal; D006321:Heart / Q000503:physiopathology*; D006352:Heart Ventricles; D017379:Hypertrophy, Left Ventricular / Q000209:etiology / Q000503:physiopathology*; D007150:Immunohistochemistry; D009206:Myocardium / Q000378:metabolism / Q000473:pathology*; D011312:Pressure; D012333:RNA, Messenger / Q000032:analysis; D051381:Rats; D044140:Receptor, Angiotensin, Type 1; D011945:Receptors, Angiotensin / Q000235:genetics / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction
chemical_list: D012333:RNA, Messenger; D044140:Receptor, Angiotensin, Type 1; D011945:Receptors, Angiotensin; D000804:Angiotensin II